Cargando…
Equivalence and noninferiority trials – are they viable alternatives for registration of new drugs? (III)
The scientific community's reliance on active-controlled trials is steadily increasing, as widespread agreement emerges concerning the role of these trials as viable alternatives to placebo trials. These trials present substantial challenges with regard to design and interpretation as their com...
Autor principal: | |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC514891/ https://www.ncbi.nlm.nih.gov/pubmed/15312236 http://dx.doi.org/10.1186/1468-6708-5-8 |